← Evidence map

ArticleCellular and molecular gastroenterology and hepatology2025

Sorafenib and Treg Differentiation: A Paradigm Shift in Hepatocellular Carcinoma Management.

Hanyang LiuPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39999950